BRIEF published on 11/07/2025 at 08:05, 7 months 22 days ago Molten Ventures Announces Share Buyback Details Shareholder Value Share Buyback Molten Ventures Capital Management Stockbrokers
PRESS RELEASE published on 11/07/2025 at 08:00, 7 months 22 days ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announces the purchase of 30,000 ordinary shares at prices ranging from 445.80p to 466.80p in accordance with the share repurchase program Molten Ventures Plc Share Purchase LSE GROW Share Repurchase Program
BRIEF published on 11/06/2025 at 08:35, 7 months 23 days ago Molten Ventures plc Engages in Share Repurchase Share Repurchase Stock Market Financial Strategy Molten Ventures Market Regulations
PRESS RELEASE published on 11/06/2025 at 08:30, 7 months 23 days ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announces transaction in own shares as part of share repurchase program. 30,000 ordinary shares purchased with details of pricing Share Repurchase Ordinary Shares Molten Ventures Plc Goodbody Stockbrokers LSE: GROW
BRIEF published on 11/06/2025 at 08:05, 7 months 23 days ago Molten Ventures Announces Further Realisation of Revolut Holding Share Buyback Portfolio Management Investment Strategy Molten Ventures Revolut
PRESS RELEASE published on 11/06/2025 at 08:00, 7 months 23 days ago Further partial realisation of holding in Revolut Molten Ventures plc announces further partial realisation of holding in Revolut, with cash proceeds of c.£85 million for FY26. Company balances investments with share buybacks. Half year results to be announced on 25 November 2025 Share Buyback Molten Ventures Plc Investment Revolut Partial Realisation
BRIEF published on 11/05/2025 at 08:05, 7 months 24 days ago Molten Ventures Announces Share Repurchase Details Share Repurchase Market Abuse Regulation Stock Buyback Molten Ventures Goodbody Stockbrokers
PRESS RELEASE published on 11/05/2025 at 08:00, 7 months 24 days ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announces purchase of 30,000 Ordinary Shares through share repurchase program Share Repurchase Ordinary Shares Molten Ventures Plc Goodbody Stockbrokers UC LSE: GROW
BRIEF published on 11/04/2025 at 08:05, 7 months 25 days ago Molten Ventures Executes Share Buyback Ordinary Shares Share Buyback Molten Ventures Capital Management Stock Repurchase
PRESS RELEASE published on 11/04/2025 at 08:00, 7 months 25 days ago Transaction in Own Shares Molten Ventures plc (GROW) announces transaction in own shares, purchasing 15,000 Ordinary Shares at average price of 462.9092p per share Molten Ventures Plc Own Shares GROW Transaction 462.9092p
Published on 06/29/2026 at 13:45, 19 minutes ago NuRAN Wireless Is Now SEC-Registered - 40-F Declared Effective, Nasdaq Listing One Step Closer
Published on 06/29/2026 at 13:30, 34 minutes ago Lara Exploration Announces 14,000 Metre Validation Drilling Program Underway at the Planalto Project
Published on 06/29/2026 at 13:00, 1 hour 4 minutes ago Aclara Introduces Super Pure Rare Earth Carbonate ("SPREC")
Published on 06/29/2026 at 13:00, 1 hour 4 minutes ago Temas Resources Confirms Extensive High-Grade Mineralisation and Multiple Critical Mineral Credits at La Blache
Published on 06/29/2026 at 13:00, 1 hour 4 minutes ago Noram Lithium Engages Triforce Media Inc. to Support Corporate Communications Strategy
Published on 06/29/2026 at 13:37, 27 minutes ago AI in satellite manufacturing: OHB Partners with Schwarz Digits
Published on 06/29/2026 at 13:20, 44 minutes ago Embera Partners GmbH: A New Category for European Capital Market
Published on 06/29/2026 at 12:59, 1 hour 5 minutes ago Hanseatic Global Terminals plans to acquire 20% stake in Eurogate Container Terminal Hamburg
Published on 06/29/2026 at 12:55, 1 hour 9 minutes ago Halfords Group PLC: Director/PDMR Shareholding
Published on 06/29/2026 at 10:56, 3 hours 8 minutes ago GUILLEMOT CORPORATION S.A. | Weekly report share buyback from June 22 to June 26 2026
Published on 06/26/2026 at 07:00, 3 days 7 hours ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
